Novartis India

Novartis announces strategic review of its India business

Novartis announces strategic review of its India business

19 Feb 2024

Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.

J&J, Novartis, Takeda, keen on buying controlling stake in Brazilian drug maker Hypermarcas

26 Apr 2017

Novartis India Ltd

23 Mar 2000

View details about the software product Informachine News Trackers

Latest articles

South Korean firms unveil $195 billion investment in AI and advanced industries

 South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

 HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

 Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

 AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

Trump’s biofuel goals face challenge as US plants lag EPA production targets

 Trump’s biofuel goals face challenge as US plants lag EPA production targets

Chris Wood boosts SK Hynix and Samsung bets amid South Korea chip pullback

 Chris Wood boosts SK Hynix and Samsung bets amid South Korea chip pullback

Canada backs Greenland molybdenum project with C$7 million grant

 Canada backs Greenland molybdenum project with C$7 million grant

India’s $55 billion renewable energy pipeline faces climate risks

 India’s $55 billion renewable energy pipeline faces climate risks

Suzlon wins 400 MW Tata Power order, crosses 1 GW partnership milestone

 Suzlon wins 400 MW Tata Power order, crosses 1 GW partnership milestone